http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012225946-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35001ca8bd47d22a9c1a0b5e15fe58fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
filingDate 2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d4b6ac4a7bce14dc6c1d14637d1971
publicationDate 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012225946-A1
titleOfInvention Choline fenofibrate delayed release compositions
abstract Described are solid pharmaceutical compositions for oral administration comprising choline fenofibrate and an amount of an acid sufficient to substantially reduce a rate of dissolution of choline fenofibrate in an aqueous environment at pH 4.5 to less than about 50% in 2 hours. Processes for making the solid pharmaceutical composition for oral administration comprising: (a) mixing choline fenofibrate with an amount of an acid sufficient to substantially reduce a rate of dissolution of choline fenofibrate in an aqueous environment at pH 4.5 to less than about 50% in 2 hours; and (b) preparing a dosage form suitable for oral administration are also provided.
priorityDate 2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7569612-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008152714-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010159010-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226594421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226594422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406563
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247993036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226596501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128633517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66631322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1547484

Total number of triples: 36.